McKesson Corporation (MCK) Given a $168.00 Price Target by Mizuho Analysts
McKesson Corporation (NYSE:MCK) has been assigned a $168.00 price target by analysts at Mizuho in a research note issued to investors on Tuesday. The brokerage currently has a “hold” rating on the stock. Mizuho’s target price would indicate a potential upside of 12.19% from the company’s previous close.
MCK has been the subject of several other research reports. Royal Bank Of Canada began coverage on shares of McKesson Corporation in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $168.00 price objective for the company. Jefferies Group LLC set a $165.00 price objective on shares of McKesson Corporation and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Cowen and Company raised shares of McKesson Corporation from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $176.00 to $189.00 in a research report on Tuesday, October 10th. UBS AG reissued a “neutral” rating and issued a $166.00 price objective (up previously from $156.00) on shares of McKesson Corporation in a research report on Monday, June 26th. Finally, Leerink Swann increased their price objective on shares of McKesson Corporation to $170.00 and gave the stock a “market perform” rating in a research report on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $172.40.
Shares of McKesson Corporation (NYSE:MCK) opened at 149.75 on Tuesday. McKesson Corporation has a 12-month low of $114.53 and a 12-month high of $169.29. The firm has a market cap of $31.49 billion, a P/E ratio of 6.79 and a beta of 1.17. The company has a 50-day moving average of $151.80 and a 200 day moving average of $153.70.
McKesson Corporation (NYSE:MCK) last released its quarterly earnings data on Thursday, July 27th. The company reported $2.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.81 by ($0.35). McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The business had revenue of $51.05 billion during the quarter, compared to analyst estimates of $51.22 billion. During the same period in the previous year, the company earned $3.50 EPS. McKesson Corporation’s revenue was up 2.7% on a year-over-year basis. Equities research analysts anticipate that McKesson Corporation will post $12.06 earnings per share for the current fiscal year.
In other news, Director Marie L/Ca Knowles sold 1,083 shares of the firm’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $162.55, for a total value of $176,041.65. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO John H. Hammergren sold 99,000 shares of the firm’s stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $153.89, for a total transaction of $15,235,110.00. Following the completion of the transaction, the chief executive officer now owns 165,000 shares in the company, valued at $25,391,850. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 952,066 shares of company stock worth $145,736,987. Insiders own 1.20% of the company’s stock.
Several institutional investors have recently bought and sold shares of MCK. BlackRock Inc. lifted its position in shares of McKesson Corporation by 2,026.2% in the 1st quarter. BlackRock Inc. now owns 14,198,977 shares of the company’s stock worth $2,105,140,000 after buying an additional 13,531,173 shares during the last quarter. Ballentine Partners LLC bought a new position in shares of McKesson Corporation in the 1st quarter worth about $191,000. Parnassus Investments CA lifted its position in shares of McKesson Corporation by 310.0% in the 1st quarter. Parnassus Investments CA now owns 4,280,594 shares of the company’s stock worth $620,727,000 after buying an additional 3,236,594 shares during the last quarter. Capital Research Global Investors lifted its position in shares of McKesson Corporation by 27.3% in the 3rd quarter. Capital Research Global Investors now owns 11,486,482 shares of the company’s stock worth $1,915,371,000 after buying an additional 2,465,070 shares during the last quarter. Finally, Boston Partners lifted its position in shares of McKesson Corporation by 108.6% in the 2nd quarter. Boston Partners now owns 4,659,692 shares of the company’s stock worth $869,731,000 after buying an additional 2,425,685 shares during the last quarter. Institutional investors own 85.29% of the company’s stock.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.